Michael R Minogue Abiomed Inc (ABMD) insider trading activity

Michael R Minogue is CHAIRMAN, PRESIDENT, CEO of ABIOMED INC. Currently has a direct ownership of 0 shares of ABMD, which is worth approximately $0. The most recent transaction as insider was on Dec 22, 2022, when has been sold 166,670 shares (Common Stock $.01 Par Value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

MICHAEL R MINOGUE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2022	SELL Sale (or disposition) back to the issuer	-	166,670 Reduced 100.0%	0 Common Stock $.01 Par ...
Dec 16 2022	BUY Grant, award, or other acquisition	-	1 Added 0.0%	136,086 Common Stock $.01 Par ...
Nov 05 2022	SELL Payment of exercise price or tax liability	$1,931,284 $373.99 p/Share	5,164 Reduced 2.04%	248,146 Common Stock $.01 Par ...
Sep 30 2022	BUY Grant, award, or other acquisition	-	32 Added 0.01%	253,310 Common Stock $.01 Par ...
May 29 2022	SELL Payment of exercise price or tax liability	$1,456,613 $266.34 p/Share	5,469 Reduced 2.11%	253,278 Common Stock $.01 Par ...
May 29 2022	BUY Grant, award, or other acquisition	-	8,806 Added 3.29%	258,747 Common Stock $.01 Par ...
May 26 2022	BUY Grant, award, or other acquisition	-	21,393 Added 7.88%	249,941 Common Stock $.01 Par ...
May 25 2022	SELL Payment of exercise price or tax liability	$313,481 $249.19 p/Share	1,258 Reduced 0.55%	228,548 Common Stock $.01 Par ...
Mar 31 2022	BUY Grant, award, or other acquisition	-	43 Added 0.02%	229,806 Common Stock $.01 Par ...
Nov 03 2021	SELL Payment of exercise price or tax liability	$1,804,062 $349.76 p/Share	5,158 Reduced 2.2%	229,763 Common Stock $.01 Par ...
Nov 03 2021	BUY Grant, award, or other acquisition	-	23,250 Added 9.01%	234,921 Common Stock $.01 Par ...
Sep 30 2021	BUY Grant, award, or other acquisition	-	36 Added 0.02%	211,671 Common Stock $.01 Par ...
Aug 23 2021	SELL Open market or private sale	$1,222,200 $350.0 p/Share	3,492 Reduced 1.62%	211,635 Common Stock $.01 Par ...
Aug 23 2021	BUY Exercise of conversion of derivative security	$80,840 $23.15 p/Share	3,492 Added 1.6%	215,127 Common Stock $.01 Par ...
Aug 09 2021	SELL Open market or private sale	$2,462,950 $350.0 p/Share	7,037 Reduced 3.22%	211,635 Common Stock $.01 Par ...
Aug 09 2021	BUY Exercise of conversion of derivative security	$162,907 $23.15 p/Share	7,037 Added 3.12%	218,672 Common Stock $.01 Par ...
Aug 06 2021	SELL Open market or private sale	$8,564,850 $350.0 p/Share	24,471 Reduced 10.36%	211,635 Common Stock $.01 Par ...
Aug 06 2021	BUY Exercise of conversion of derivative security	$566,504 $23.15 p/Share	24,471 Added 9.39%	236,106 Common Stock $.01 Par ...
Aug 05 2021	SELL Open market or private sale	$8,583,500 $343.34 p/Share	25,000 Reduced 10.56%	211,635 Common Stock $.01 Par ...
Aug 05 2021	BUY Exercise of conversion of derivative security	$578,750 $23.15 p/Share	25,000 Added 9.56%	236,635 Common Stock $.01 Par ...
Jun 21 2021	SELL Open market or private sale	$8,140,000 $325.6 p/Share	25,000 Reduced 10.56%	211,635 Common Stock $.01 Par ...
Jun 21 2021	BUY Exercise of conversion of derivative security	$578,750 $23.15 p/Share	25,000 Added 9.56%	236,635 Common Stock $.01 Par ...
May 29 2021	SELL Payment of exercise price or tax liability	$444,799 $284.58 p/Share	1,563 Reduced 0.73%	211,635 Common Stock $.01 Par ...
May 25 2021	BUY Grant, award, or other acquisition	-	8,503 Added 3.84%	213,198 Common Stock $.01 Par ...
May 16 2021	SELL Payment of exercise price or tax liability	$1,653,792 $268.56 p/Share	6,158 Reduced 2.92%	204,695 Common Stock $.01 Par ...

Also insider at

PODD

INSULET CORP Healthcare

Director

MRM